Safety and tolerance is going really well for them to be rewarded the chance of an extra cohort,
... so we'll get extra data for the FDA with results still due next quarter - excellent!
- Forums
- ASX - By Stock
- NYR
- Ann: Phase I Clinical Trial Protocol Amendment
NYR
nyrada inc.
Add to My Watchlist
4.26%
!
24.5¢

Ann: Phase I Clinical Trial Protocol Amendment, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.5¢ |
Change
0.010(4.26%) |
Mkt cap ! $51.67M |
Open | High | Low | Value | Volume |
23.0¢ | 25.0¢ | 23.0¢ | $143.6K | 590.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 60000 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 159081 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60000 | 0.240 |
1 | 100000 | 0.225 |
7 | 184773 | 0.220 |
1 | 100000 | 0.215 |
5 | 45669 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 159081 | 1 |
0.250 | 100000 | 1 |
0.255 | 227249 | 4 |
0.260 | 96421 | 4 |
0.270 | 100000 | 1 |
Last trade - 15.59pm 20/06/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |